Description
P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool
Article: P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool
€3.03
Related products
-
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: INTRODUCTION
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart
Reviews
There are no reviews yet.